Table 1. The baseline characteristics of included studies.
Author, year | Ethnicity | Cancer type | Sample | Na | Male | Female | Survival | Analysis | mtDNA gene | nDNA gene | NOS score |
---|---|---|---|---|---|---|---|---|---|---|---|
Bai25 | Asian | Breast cancer | Tissue | 148 | 0 | 148 | OS | MV | tRNA-Leu (UUR) | B2M | 4 |
Chang26 | Asian | Colorectal cancer | Tissue | 194 | 134 | 60 | DFS | MV | MT-CYB | RNase P gene | 9 |
Chen20 | Asian | Glioma | Blood | 336 | 189 | 147 | OS/PFS | MV | MT-ND1 | HGB | 7 |
Cui18 | Asian | Colorectal cancer | Tissue | 60 | 30 | 30 | OS | UV | MT-ND1 | β-actin | 9 |
Dang27 | Asian | Laryngeal cancer | Tissue | 204 | 197 | 7 | OS | MV | MT-ND2 | β-actin | 9 |
Feng, 2015 | Asian | Cervical cancer | Tissue | 122b | NA | NA | OS | MV | NC_012920 region | B2M | 8 |
He21 | Asian | HCC | Blood | 618 | 544 | 74 | OS/DFS | MV | MT-ND1 | HGB | 9 |
Lee22 | Asian | Gastric cancer | Tissue | 109 | 82 | 27 | OS/DFS | UV | MT-COX1 | β-actin | 6 |
Lin28 | Asian | Head and neck cancer | Blood | 75 | 75 | 0 | OS | UV | MT-tRNAleu | 18 S | 6 |
Mohideen17 | Caucasian | Colorectal cancer | Blood | 273c | 160 | 116 | OS/DFS | MV | MT-ND2 | FASLG | 8 |
Osch16 | Caucasian | Colorectal cancer | Tissue | 655c | 372 | 306 | OS | UV | D-loop | B2M | 8 |
Qu29 | Asian | Colorectal cancer | Blood | 598 | 328 | 270 | OS/DFS | MV/UV | MT-ND1 | HGB | 8 |
Tu, 2015 | Caucasian | Prostate cancer | Blood | 1266 | 1266 | 0 | PFS | MV | MT-ND1 | HGB | 7 |
Wang30 | Asian | Colorectal cancer | Tissue | 124c | 72 | 90 | OS | UV | MT-ND1 | β-actin | 7 |
Weerts31 | Caucasian | Breast cancer | Tissue | 186b | NA | NA | DMFS | MV | MT-TL1 | HMBS | 7 |
Xu32 | Asian | NSCLC | Tissue | 128 | 95 | 33 | OS | MV | NC_012920 region | B2M | 8 |
Yamada33 | Asian | HCC | Tissue | 31 | 27 | 4 | OS | UV | mtDNA | β-actin | 8 |
Yu34 | Asian | Breast cancer | Tissue | 59 | 0 | 59 | OS/DFS | UV | D-loop | β-actin | 6 |
Zhang35 | Asian | Gastric cancer | Tissue | 103 | 84 | 19 | OS | MV | MT-ND1 | β-actin | 8 |
Zhang36 | Asian | Glioma | Tissue | 124 | 68 | 56 | OS | MV | MT-ND1 | β-actin | 8 |
aNumber of included patients; bUnknown information of gender; cexisting missing data.
NOS: Newcastle-Ottawa Quality Assessment Scale; OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; DMFS: distant metastasis-free survival; MV: multivariate analysis; UV: univariate analysis; NSCLC: non-small cell lung cancer; HCC: hepatocellular carcinoma.